Chemoradiotherapy using retrograde superselective intra-arterial infusion for tongue cancer: Analysis of therapeutic results in 118 cases

The tongue is the most common site of oral cavity cancer, the incidence of which has been found to be rapidly increasing. Patients with squamous cell carcinoma (SCC) of the tongue have a significantly worse prognosis than patients with other oral cavity and other head and neck cancers, because of the high rates of local recurrence following definitive treatment [1]. Early stage tongue SCC is treated by glossectomy or definitive radiotherapy including interstitial brachytherapy. For patients with locally advanced oral SCC, including tongue SCC, primary surgery is widely accepted as the standard treatment, and adjuvant concurrent chemoradiotherapy (CRT) is of benefit in patients with nodal disease [2,3].

Source: Oral Oncology - March 8, 2018 Category: Cancer & Oncology Authors: Kenji Mitsudo, Yuichiro Hayashi, Shuhei Minamiyama, Nobuhide Ohashi, Masaki Iida, Toshinori Iwai, Senri Oguri, Toshiyuki Koizumi, Mitomu Kioi, Makoto Hirota, Izumi Koike, Masaharu Hata, Iwai Tohnai Source Type: research